Foghorn Therapeutics Inc.
FHTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001822462
No open-market purchases or sales by Foghorn Therapeutics Inc. insiders were filed in the last 90 days; 102 institutions reported holding it in 13F filings for Q2 2026, worth $219.2M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Foghorn Therapeutics Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 93 | 1 | 105 | +13 |
| Shares | 41.9M | 1.93M | 44.4M | +4.49M (+11.3%) |
| Value | $226.1M | $10.4M | $212.4M | −$3.28M (−1.5%) |
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (22)
Institutions that held Foghorn Therapeutics Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Capital Management LLC | 1,495,089 | $7.15M | 0.00% |
| Candriam Luxembourg S.C.A. | 313,765 | $1.50M | 0.01% |
| Vanguard Portfolio Management LLC | 255,931 | $1.22M | 0.00% |
| Vanguard Fiduciary Trust Co | 240,586 | $1.15M | 0.00% |
| B Group, Inc. | 102,000 | $487.6K | 0.36% |
| Trexquant Investment LP | 30,111 | $143.9K | 0.00% |
| Verdad Advisers, LP | 24,416 | $116.7K | 0.13% |
| Vanguard Global Advisers, LLC | 12,833 | $61.3K | 0.00% |
| Kingswood Wealth Advisors, LLC | 12,500 | $59.8K | 0.00% |
| Sphera Funds Management Ltd. | 12,224 | $58.4K | 0.01% |
| Prudential Financial Inc | 12,205 | $58.3K | 0.00% |
| Susquehanna International Group, LLP | 11,637 | $55.6K | 0.00% |
| Diversified Trust Co | 10,852 | $51.9K | 0.00% |
| Northwestern Mutual Wealth Management Co | 5,295 | $25.3K | 0.00% |
| Essential Partners LLC | 112 | $535 | 0.00% |
| Allworth Financial LP | 97 | $464 | 0.00% |
| Simplex Trading, LLC | 66 | $315 | 0.00% |
| MAI Capital Management | 35 | $168 | 0.00% |
| Rothschild Investment LLC | 34 | $163 | 0.00% |
| Root Financial Partners, LLC | 28 | $134 | 0.00% |
| Wealth Preservation Advisors, LLC | 13 | $62 | 0.00% |
| Farther Finance Advisors, LLC | 9 | $44 | 0.00% |
Sold out (9)
Institutions that held Foghorn Therapeutics Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Jane Street Group, LLC | 132,501 | $715.5K |
| Marshall Wace, LLP | 28,893 | $156.0K |
| Two Sigma Investments, LP | 16,600 | $89.6K |
| XTX Topco Ltd | 15,662 | $84.6K |
| Intech Investment Management LLC | 14,576 | $78.7K |
| Brevan Howard Capital Management LP | 10,486 | $56.6K |
| Two Sigma Advisers, LP | 10,400 | $56.2K |
| Brummer Multi-Strategy AB | 4,708 | $25.4K |
| Amalgamated Bank | 1,046 | $6.00K |
Not filed for Q1 2026 yet (1)
Institutions that held Foghorn Therapeutics Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 1,928,992 | $10.4M |